Abatacept

In the US, Abatacept (abatacept systemic) is a member of the following drug classes: antirheumatics, selective immunosuppressants and is used to treat Juvenile Idiopathic Arthritis and Rheumatoid Arthritis.

US matches:

• Abatacept


• Abatacept Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L04AA24

CAS registry number (Chemical Abstracts Service)

0332348-12-6

Chemical Formula

C3750-H5872-N982-O1154-S38

Molecular Weight

84395

Therapeutic Categories

Selective immunosuppressant

Anti-inflammatory agent

Disease-modifying antirheumatic drug, DMARD

Monoclonal antibody

Chemical Name

1-25-Oncostatin M (human precursor) fusion protein with CTLA-4 (antigen)(human) fusion protein with immunoglobulin G1 (human heavy chain fragment), bimoleucular (146 -> 146')-disulfide (WHO)

Foreign Names

• Abataceptum (Latin)
• Abatacept (German)
• Abatacept (French)
• Abatacept (Spanish)

Generic Names

• Abatacept (OS: BAN, USAN)
• BMS 188667 (IS: Bristol-Myers)
• CTLA4-Ig (IS)

Brand Names

• Orencia
  Bristol-Myers Squibb, Argentina; Bristol-Myers Squibb, Austria; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Spain; Bristol-Myers Squibb, France; Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Hungary; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Netherlands; Bristol-Myers Squibb, Norway; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, Slovakia; Bristol-Myers Squibb, United States; Bristol-Myers Squibb Phar, Luxembourg



• Orenica
  Bristol-Myers Squibb, United Kingdom; Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, New Zealand; Bristol-Myers Squibb, Slovenia

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.